Staretz-Chacham, O, Lang, TC, LaMarca, ME, Krasnewich, D, Sidransky, E. Lysosomal storage disorders in the newborn. Pediatrics. 2009;123(4):1191–207.Google Scholar

Belletatto, CM, Hubert, L, Scarpa, M, Wangler, MF. Inborn errors of metabolism involving complex molecules: lysosomal and peroxisomal storage diseases. Pediatr Clin North Am. 2018;65(2):353–73.Google Scholar

Wang, RY, Bodamer, OA, Watson, MS, Wilcox, WR, ACMG Work Group on Diagnostic Confirmation of Lysosomal Storage Diseases. Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals. Genet Med. 2011;13(5):457–84.Google Scholar

Anderson, S. Newborn screening for lysosomal storage disorders. J Pediatr Health Care. 2018;32(3):285–94.Google Scholar

Filocamo, M, Morrone, A. Lysosomal storage disorders: molecular basis and laboratory testing. Hum Genomics. 2011;5(3):156–69.Google Scholar

Schielen, PCJI, Kemper, EA, Gelb, MH. Newborn screening for lysosomal storage diseases: a concise review of the literature on screening methods, therapeutic possibilities and regional programs. Int J Neonatal Screen. 2017;3(2)pii:6.Google Scholar

Pastores, GM. Therapeutic approaches for lysosomal storage diseases. Ther Adv Endocrinol Metab. 2010;1(4):177–88.Google Scholar

Platt, FM, Boland, B, van der Spoel, AC. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol. 2012;199(5):723–34.CrossRefGoogle ScholarPubMed

Ferreira, CR, Gahl, WA. Lysosomal storage diseases. Transl Sci Rare Dis. 2017;2(1–2):1–71.Google Scholar

Giugliani, R, Federhen, A, Michelin-Tirelli, K, Riegel, M, Burin, M. Relative frequency and estimated minimal frequency of lysosomal storage diseases in Brazil: report from a reference laboratory. Genet Mol Biol. 2017;40(1):31–9.Google Scholar

Al-Jasmi, FA, Tawfig, N, Berniah, A, et al. Prevalence and novel mutations of lysosomal storage disorders in the United Arab Emirates: LSD in UAE. JIMD Rep. 2013;10:1–9.Google Scholar

Kingma, SD, Bodamer, OA, Wijburg, FA. Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening. Best Pract Res Clin Endocrinol Metab. 2015;29:145–57.CrossRefGoogle ScholarPubMed

Fuller, M, Meikle, PJ, Hopwood, JJ. Epidemiology of lysosomal storage disease: An overview. In: Mehta, A, Beck, M, Sunder-Plassman, G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford PharmaGenetics; Oxford: 2006. pp. 9–20.Google Scholar

Biffi, A. Gene therapy for lysosomal storage disorders: a good start. Hum Mol Genet. 2016;25(R1): R65–75.Google Scholar

Faverio, P, et al. Molecular pathways and respiratory involvement in lysosomal storage diseases. Int J Mol Sci. 2019;20(2):327.Google Scholar

D’Arco, F, Hanagandi, P, Ganau, M, Krishnan, P, Taranth, A. Neuroimaging findings in lysosomal disorders: 2018 update. Top Magn Reson Imaging. 2018;27(4):259–74.Google Scholar

Palmucci, S, Attinà, G, Lanza, ML, et al. Imaging findings of mucopolysaccharidoses: a pictorial review. Insights Imaging. 2013;4(4):443–59.Google Scholar

Xing, M, Parker, EI, Moreno-De-Luca, A, Harmouche, E, Terk, MR. Radiological and clinical characterization of lysosomal storage disorders: non-lipid disorders. Br J Radiol. 2014;87:20130467.CrossRefGoogle Scholar

Collardeau-Frachon, S, Cordier, MP, Rossi, M, Guibaud, L, Vianey-Saban, C. Antenatal manifestations of inborn errors of metabolism: autopsy findings suggestive of a metabolic disorder. J Inherit Metab Dis. 2016;39(5):597–610.CrossRefGoogle ScholarPubMed

Simpson, WL, Hermann, G, Balwani, M. Imaging of Gaucher disease. World J Radiol. 2014;6(9):657–68.CrossRefGoogle ScholarPubMed

Mistri, M, Oza, N, Sheth, F, Sheth, J. Prenatal diagnosis of lysosomal storage disorders: our experience in 120 cases. Mol Cytogenet. 2014;7(Suppl. 1):P126.Google Scholar

Verma, J, Bijarnia-Mahav, S, Verna, IC. Prenatal diagnosis of lysosomal storage disorders using chorionic villi. Methods Mol Biol. 2017;1594:265–91.CrossRefGoogle ScholarPubMed

Yu, C, Sun, Q, Zhou, H. Enzymatic screening and diagnosis of lysosomal storage diseases. N Am J Med Sci. 2013;6(4):186–93.Google Scholar

Mokhtariye, A, Hagh-Nazari, L Varasteh, AR, Keyfi, F. Diagnostic methods for Lysosomal Storage Disease.Rep Biochem Mol Biol. 2019;7(2):119–28.Google ScholarPubMed

Schlotawa, L, Adang, L, De Castro, M, Ahrens-Nicklas, R. Multiple sulfatase deficiency. Gene Reviews. Initial posting: March 21, 2019. Available at: https://www.ncbi.nlm.nih.gov/books/NBK538937/.Google Scholar

Nita, DA, Mole, SE, Minassian, BA. Neuronal ceroid lipofuscinoses. Epileptic Disord. 2016;18(S2):73–88.CrossRefGoogle ScholarPubMed

Radke, J, Stenzel, W, Goebel, HH. Human NCL neuropathology. Biochim Biophys Acta. 2015; 1852: 2262–6.Google Scholar

Mole, SE, Anderson, G, Band, HA, Berkovic, SF, Cooper, JD, Kleine Holthaus, SM, et al. Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol. 2019;18(1):107–16.Google Scholar

Johnson, TB, Cain, JT, White, KA, Ramirez-Montealegre, D, Pearce, DA, Weimer, JM. Therapeutic landscape for Batten disease: current treatments and future prospects. Nat Rev Neurol. 2019;15(3):161–78.CrossRefGoogle ScholarPubMed

Belletatto, CM, Hubert, L, Scarpa, M, Wangler, MF. Inborn errors of metabolism involving complex molecules: lysosomal and peroxisomal storage diseases. Pediatr Clin North Am. 2018;65(2):353–73.Google Scholar

Argyriou, C, D’Agostino, MD, Braverman, N. Peroxisome biogenesis disorders. Transl Sci Rare Dis. 2016;1(2):111–44.Google ScholarPubMed

Berger, J, Dorninger, F, Forss-Petter, S, Kunze, M. Peroxisomes in brain development and function. Biochim Biophys Acta. 2015;1863(5):934–55.Google Scholar

Waterham, HR, Ebberink, MS. Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta. 2012;1822(9):1430–41.Google Scholar

Wanders, RJA. Clinical, biochemical and genetic aspects of peroxisomal disorders – an expanding group of genetic diseases in humans. Hamdan Med J. 2012;5:313–26.Google Scholar

Wanders, RJ, Waterham, HR. Peroxisomal disorders: the single peroxisomal enzyme deficiencies. Biochim Biophys Acta. 2006;1763(12):1707–20.Google Scholar

Delille, HK, Bonekamp, NA, Schrader, M. Peroxisomes and disease – an overview. Int J Biomed Sci. 2006;2(4):308–14.Google Scholar

Waterham, HR, Ferdinandusse, S, Wanders, RJ. Human disorders of peroxisome metabolism and biogenesis. Biochim Biophys Acta. 2016;1863(5):922–33.Google Scholar

Poll-The, BT, Gärtner, L. Clinical diagnosis, biochemical findings and MRI spectrum of peroxisomal disorders. Biochimica et Biophysica Acta. 2012;1822:1421–9.Google ScholarPubMed

Klouwer, FC, Berendse, K, Ferdinandusse, S, Wanders, RJ, Engelen, M, Poll-The, BT. Zellweger spectrum disorders: clinical overview and management approach. Orphanet J Rare Dis. 2015;10:151.Google Scholar

Baes, M, Van Veldhoven, PP. Hepatic dysfunction in peroxisomal disorders. Biochim Biophys Acta. 2016;1863(5):956–70.Google Scholar

Tan, AP, Gonçalves, FG, Almehdar, A, Soares, BP. Clinical and neuroimaging spectrum of peroxisomal disorders. Top Magn Reson Imaging. 2018;27(4):241–57.Google Scholar

Wanders, RJ, Ofman, R, Romeijn, GJ, Schutgens, RB, Mooijer, PA, Dekker, C, van den Bosch, H. Measurement of dihydroxyacetone-phosphate acyltransferase (DHAPAT) in chorionic villous samples, blood cells and cultured cells. J Inherit Metab Dis. 1995;18(Suppl 1):90–100.Google Scholar

Kutukcu, B, Topcu, M, Bekcas, MS, Wanders, RJ. Prenatal diagnosis of Zellweger syndrome: case report. Gynecol Obstet Reprod. Med 2013;19:31–33.Google Scholar

Wanders, RJA, Waterham, HR, Ferdinandusse, S. Peroxisomes and their central role in metabolic interaction networks in humans. Subcell Biochem. 2018;89:345–65.Google Scholar

Collardeau-Frachon, S, Cordier, MP, Rossi, M, Guibaud, L, Vianey-Saban, C. Antenatal manifestations of inborn errors of metabolism: autopsy findings suggestive of a metabolic disorder. J Inherit Metab Dis. 2016;39(5):597–610.Google Scholar

Ohashi, T. Gene therapy for lysosomal storage diseases and peroxisomal diseases. J Hum Genet. 2019;64(2):139–43.Google Scholar

Heubi, JE, Bishop, WP. Long-term cholic acid treatment in a patient with Zellweger spectrum disorder. Case Rep Gastroenterol. 2018;12(3):661–70.Google Scholar

Shapiro, SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol 2003;29(5):410–21.Google Scholar

Watchko, JF, Maisels, MJ. Jaundice in low birthweight infants: pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed. 2003;88:F455–8.Google Scholar

Okumura, A, Kidokoro, H, Shoji, H, et al. Kernicterus in preterm infants. Pediatrics 2009;123:e1052–8.Google Scholar

Bhutani, VK, Johnson, LH, Shapiro, SM. Kernicterus in sick and preterm infants (1999–2002): a need for an effective preventive approach. Semin Perinatol. 2004;28:319–25.Google Scholar

Wickremasinghe, AC, Kuzniewicz, MW, Newman, TB. Black race is not protective against hazardous bilirubin levels. J Pediatr. 2013;162:1068–9.Google Scholar

Kuzniewicz, MW, Wickremasinghe, AC, Wu, YW, et al. Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics 2014;134:504–9.Google Scholar

Sgro, M, Kandasamy, S, Shah, V, et al. Severe neonatal hyperbilirubinemia decreased after the 2007 Canadian Guidelines. J Pediatr. 2016;171:43–7.Google Scholar

Stevenson, DK, Vreman, HJ, Wong, RJ. Bilirubin production and the risk of bilirubin neurotoxicity. Semin Perinatol. 2011;35:121–6.Google Scholar

Bhutani, VK, Johnson, L. Synopsis report from the pilot USA Kernicterus Registry. J Perinatol. 2009;1:S4–7.Google Scholar

Johnson, L, Bhutani, VK, Karp, K, Sivieri, EM, Shapiro, SM. Clinical report from the pilot USA Kernicterus Registry (1992–2004). J Perinatol. 2009;1:S25–45.CrossRefGoogle Scholar

Ghersi-Egea, JF, Gazzin, S, Strazielle, N. Blood-brain interfaces and bilirubin induced neurological disease. Curr Pharm Des. 2009;15:2893–907.Google Scholar

Brites, D. Bilirubin injury to neurons and glial cells: new players, novel targets and newer insights. Semin Perinatal. 2011;35(3):114–20.Google Scholar

Watchko, JF. Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns. Neuromolecular Med. 2006;8:513–29.CrossRefGoogle ScholarPubMed

Amin, SB, Charafeddine, L, Guillet, R. Transient bilirubin encephalopathy and apnea of prematurity in 28 to 32 weeks gestational age infants. J Perinatol. 2005;25:386–90.Google Scholar

Amin, SB. Clinical assessment of bilirubin-induced neurotoxicity in premature infants. Semin Perinatol. 2004;28:340–7.Google Scholar

Ahlfors, CE, Amin, SB, Parker, AE. Unbound bilirubin predicts abnormal automated auditory brainstem response in a diverse newborn population. J Perinatol. 2009;29:305–9.CrossRefGoogle Scholar

Amin, SB, Wang, H. Bilirubin albumin binding and unbound unconjugated hyperbilirubinemia in premature infants. J Pediatr. 2018;192:47–52.Google Scholar

Nagar, G, Vandermeer, B, Campbell, S, Kumar, M. Reliability of transcutaneous bilirubin devices in preterm infants: a systematic review. Pediatrics 2013;132:871–81.Google Scholar

Maisels, MJ, Coffey, MP, Kring, E. Transcutaneous bilirubin levels in newborns <35 weeks’ gestation. J Perinatol. 2015;35:739–44.Google Scholar

Wennberg, RP, Ahlfors, CE, Bhutani, VK, et al. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006;117:474–85.Google Scholar

Nakamura, H, Yonetani, M, Uetani, Y, et al. Determination of serum unbound bilirubin for prediction of kernicterus in low birthweight infants. Acta Paediatr Jpn. 1992;34:642–7.Google Scholar

Hulzebos, CV, van Imhoff, DE, Bos, AF, et al. Usefulness of the bilirubin/albumin ratio for predicting bilirubin-induced neurotoxicity in premature infants. Arch Dis Child Fetal Neonatal Ed. 2008;93:F384–8.Google Scholar

Oh, W, Stevenson, DK, Tyson, JE, et al. Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta Paediatr. 2010;99:673–8.Google Scholar

Ahlfors, CE. Criteria for exchange transfusion in jaundiced newborns. Pediatrics 1994;93:488–94.Google Scholar

Ahdab-Barmada, M, Moossy, J. Theneuropathology of kernicterus in the premature neonate: diagnostic problems. J Neuropathol Exp Neurol. 1984;43(1):45–56.Google Scholar

Sherwood, AJ, Smith, JF. Bilirubin encephalopathy. Neuropathol Appl Neurobiol. 1983;9(4):271–285.Google Scholar

Zuelzer, WW, Mudgett, RT. Kernicterus; etiologic study based on an analysis of 55 cases. Pediatrics 1950;6:452–474.Google Scholar

Kumada, S, Hayashi, M, Umitsu, R, et al. Neuropathology of the dentate nucleus in developmental disorders. Acta Neuropathol. 1997;94(1):36–41Google Scholar

Dublin, WB. Neurologic lesions of erythroblastosis fetalis in relation to nuclear deafness. AM J Clin Pathol. 1951;21(10):935–9.Google Scholar

Gerrard, J. Nuclear jaundice and deafness. J Laryngol Otol. 1952;66(1):39–46.CrossRefGoogle ScholarPubMed

Brito, MA, Zurolo, E, Pereira, P, et al. Cerebellar axon/myelin loss, angiogenic sprouting, and neuronal increase of vascular endothelial growth factor in a preterm infant with kernicterus. J Child Neurol. 2012;27(5):615–24.Google Scholar

Hachiya, Y, Hayashi, M. Bilirubin encephalopathy: a study of neuronal subpopulations and neurodegenerative mechanisms in 12 autopsy cases. Brain Dev. 2008;30:269–78.Google Scholar

Lipsitz, PJ, Gartner, LM, Bryla, DA. Neonatal and infant mortality in relation to phototherapy. Pediatrics 1985;75:422–6.Google Scholar

Tyson, JE, Pedroza, C, Langer, J, et al. Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? J Perinatol. 2012;32:677–84.Google Scholar

Okwundu, CI, Okoromah, CA, Shah, PS. Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. Cochrane Database Syst Rev. 2012;1:CD007966.Google Scholar

Lee, KS, Gartner, LM. Management of unconjugated hyperbilirubinemia in the newborn. Semin Liver Dis. 1983;3:52–64.Google Scholar

Brown, AK, Kim, MH, Wu, PY, Bryla, DA. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 1985;75:393–400.Google Scholar

Wusthoff, CJ, Loe, IM. Impact of bilirubin-induced neurologic dysfunction on neurodevelopmental outcomes. Semin Fetal Neonatal Med. 2015;20(1):52–7.Google Scholar

Rose, J, Vassar, R. Movement disorders due to bilirubin toxicity. Semin Fetal Neonatal Med. 2014;20(1):20–5.Google Scholar

Gorman, GS, Chinnery, PF, DiMauro, S, Hirano, M, Koga, Y, McFarland, R, et al. Mitochondrial diseases. Nat Rev Dis Primers. 2016;2:16080.Google Scholar

Skladal, D, Halliday, J, Thorburn, DR. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain. 2003;126(Pt 8):1905–12.Google Scholar

Tulinius, M, Oldfors, A. Neonatal muscular manifestations in mitochondrial disorders. Semin Fetal Neonatal Med. 2011;16(4):229–35.Google Scholar

Anderson, S, Bankier, AT, Barrell, BG, de Bruijn, MH, Coulson, AR, Drouin, J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981 290(5806):457–65.Google Scholar

Fu, Q, Li, H, Moorjani, P, Jay, F, Slepchenko, SM, Bondarev, AA, et al. Genome sequence of a 45,000-year-old modern human from western Siberia. Nature. 2014 514(7523):445–9.CrossRefGoogle ScholarPubMed

O’Ferrall., Erin Mitochondrial structure, function, and genetics [Internet]. Shefner JF, Sihoun Hahn, Dashe JF, editors. UpToDate. [cited May 5, 2019]. Available from: www.uptodate.com/contents/mitochondrial-structure-function-and-genetics.Google Scholar

Mitochondrial Disorder Medical Information [Internet]. MitoAction. [cited May 5, 2019]. Available from: www.mitoaction.org/medical-information.Google Scholar

Chi, C-S. Diagnostic approach in infants and children with mitochondrial diseases. Pediatrics & Neonatology. 2015 Feb;56(1):7–18.Google Scholar

Friede, RL. Developmental neuropathology [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 1989.Google Scholar

Mascalchi, M, Montomoli, M, Guerrini, R. Neuroimaging in mitochondrial disorders. Essays In Biochemistry. 2018 Jul 20;62(3):409–21.Google Scholar

Chinnery, PF. Mitochondrial disorders overview. In: Adam, MP, Ardinger, HH, Pagon, RA, Wallace, SE, Bean, LJ, Stephens, K, et al., editors. GeneReviews. Seattle: University of Washington; 1993 [cited May 5, 2019]. Available from: www.ncbi.nlm.nih.gov/books/NBK1224/.Google Scholar

White, SL, Shanske, S, McGill, JJ, Mountain, H, Geraghty, MT, DiMauro, S, et al. Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue- or age-related variation. J Inherit Metab Dis. 1999;22(8):899–914.Google Scholar

Hellebrekers, DMEI, Wolfe, R, Hendrickx, ATM, IFM, de Coo, de Die, CE, Geraedts, JPM, et al. PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring. Human Reproduction Update. 2012 Jul;18(4):341–9.Google Scholar

Nishihara, H, Omoto, M, Takao, M, Higuchi, Y, Koga, M, Kawai, M, et al. Autopsy case of the C12orf65 mutation in a patient with signs of mitochondrial dysfunction. Neurology Genetics. 2017; 3(4):e171.Google Scholar

Alston, CL, Rocha, MC, Lax, NZ, Turnbull, DM, Taylor, RW. The genetics and pathology of mitochondrial disease. J Pathol. 2017;241(2):236–50.Google Scholar

Khan, NA, Govindaraj, P, Meena, AK, Thangaraj, K. Mitochondrial disorders: challenges in diagnosis & treatment. Indian J Med Res. 2015;141(1):13–26.Google Scholar

Engel, WK, Cunningham, GG. Rapid examination of muscle tissue: an improved trichrome method for fresh-frozen biopsy sections. Neurology. 1963;13:919–23.Google Scholar

Saneto, RP. Genetics of mitochondrial disease. In: Advances in Genetics [Internet]. Elsevier; 2017 [cited May 5, 2019]. pp. 63–116. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0065266017300032.Google Scholar

United Mitochondrial Disease Foundation. Types of mitochondrial disease [Internet]. UMDF. 2018 [cited May 5, 2019]. Available from: www.umdf.org/types/.Google Scholar

Zhang, J, Guo, J, Fang, W, Jun, Q, Shi, K. Clinical features of MELAS and its relation with A3243G gene point mutation. Int J Clin Exp Pathol. 2015;8(10):13411–15.Google Scholar

Magner, M, Kolářová, H, Honzik, T, Švandová, I, Zeman, J. Clinical manifestation of mitochondrial diseases. Dev Period Med. 2015;19(4):441–9.Google Scholar

Malhotra, K, Liebeskind, D.S. Imaging of MELAS. Curr Pain Headache Rep. 2016;20:54.Google Scholar

Fujii, T, Okuno, T, Ito, M, Motoh, K, Hamazaki, S, Okada, S, et al. CT, MRI, and autopsy findings in brain of a patient with MELAS. Pediatric Neurology. 1990;6(4):253–6.Google Scholar

Yanagihara, C, Oyama, A, Tanaka, M, Nakaji, K, Nishimura, Y. An autopsy case of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome with chronic renal failure. Internal Medicine. 2001;40(7):662–5.Google Scholar

Mima, A, Shiota, F, Matsubara, T, Iehara, N, Akagi, T, Abe, H, et al. An autopsy case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with intestinal bleeding in chronic renal failure. Renal Failure. 2011;33(6):622–5.Google Scholar

Koenig, MK, Emrick, L, Karaa, A, Korson, M, Scaglia, F, Parikh, S, et al. Recommendations for the management of strokelike episodes in patients with mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes. JAMA Neurology. 2016 73(5):591.Google Scholar

Lake, NJ, Bird, MJ, Isohanni, P, Paetau, A. Leigh syndrome: neuropathology and pathogenesis. Journal of Neuropathology & Experimental Neurology. 2015;74(6):482–92.Google Scholar

Saneto, R, Ruhoy, I. The genetics of Leigh syndrome and its implications for clinical practice and risk management. Appl Clin Genet. 2014;7:221–34.Google Scholar

Gerards, M, Sallevelt, SCEH, Smeets, HJM. Leigh syndrome: resolving the clinical and genetic heterogeneity paves the way for treatment options. Molecular Genetics and Metabolism. 2016;117(3):300–12.Google Scholar

Baertling, FL, Rodenburg, RJ, Schaper, J, Smeitink, JA, Koopman, WJ, Mayatepek, E, et al. A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry. 2014;85(3):257–65.Google Scholar

Martinelli, D, Catteruccia, M, Piemonte, F, Pastore, A, Tozzi, G, Dionisi-Vici, C, et al. EPI-743 reverses the progression of the pediatric mitochondrial disease: genetically defined Leigh syndrome. Molecular Genetics and Metabolism. 2012;107(3):383–8.Google Scholar

Wang, J, El-Hattab, AW, Wong LJ, C. TK2-related mitochondrial DNA maintenance defect, myopathic form. GeneReviews [Initial Posting: December 6, 2012; Last Update: July 26, 2018]. www.ncbi.nlm.nih.gov/books/NBK114628/.Google Scholar

Sharma, AK, Morrison, JP, Rao, DB, Pardo, ID, Garman, RH, Bolon, B. Toxicologic pathology analysis for translational neuroscience: improving human risk assessment using optimized animal data. Int J Toxicol. 2016;35(4):410–19.Google Scholar

Archer, T, Kostrzewa, RM. Neuroteratology and animal modeling of brain disorders. Current Topics in Behavioral Neurosciences. 2016;29:1–40.Google Scholar

Garman, RH, Li, AA, Kaufmann, W, Auer, RN, Bolon, B. Recommended methods for brain processing and quantitative analysis in rodent developmental neurotoxicity studies. Toxicol Pathol. 2016;44(1):14–42.Google Scholar

Li, J, Settivari, R, LeBaron, MJ, Marty, MS. An industry perspective: a streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity. Neurotoxicology. 2019;73:17–30.Google Scholar

Olney, JW. New insights and new issues in developmental neurotoxicology. Neurotoxicology. 2002;23(6):659–68.Google Scholar

Tilson, HA. The concern for developmental neurotoxicology: is it justified and what is being done about it? Environmental health perspectives. 1995;103 Suppl 6:147–51.Google Scholar

Tilson, HA. Neurotoxicology risk assessment guidelines: developmental neurotoxicology. Neurotoxicology. 2000;21(1–2):189–94.Google Scholar

Chomchai, S, Phuditshinnapatra, J, Mekavuthikul, P, Chomchai, C. Effects of unconventional recreational drug use in pregnancy. Seminars in Fetal & Neonatal Medicine. 2019;24(2):142–8.Google Scholar

Bayer, SA, Altman, J, Russo, RJ, Zhang, X. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology. 1993;14(1):83–144.Google ScholarPubMed

Bolduc, ME, Lambert, H, Ganeshamoorthy, S, Brossard-Racine, M. Structural brain abnormalities in adolescents and young adults with congenital heart defect: a systematic review. Developmental Medicine and Child Neurology. 2018;60(12):1209–24.Google Scholar

Peyvandi, S, Latal, B, Miller, SP, McQuillen, PS. The neonatal brain in critical congenital heart disease: Insights and future directions. NeuroImage. 2019;185:776–82.Google Scholar

Roozen, S, Peters, GJ, Kok, G, Townend, D, Nijhuis, J, Curfs, L. Worldwide prevalence of fetal alcohol spectrum disorders: a systematic literature review including meta-analysis. Alcohol Clin Exp Res. 2016;40(1):18–32.CrossRefGoogle ScholarPubMed

Popova, S, Lange, S, Shield, K, Burd, L, Rehm, J. Prevalence of fetal alcohol spectrum disorder among special sub-populations: a systematic review and meta-analysis. Addiction. 2019;114(7):1150–72.Google Scholar

Subramoney, S, Eastman, E, Adnams, C, Stein, DJ, Donald, KA. The early developmental outcomes of prenatal alcohol exposure: a review. Frontiers in Neurology. 2018;9:1108.Google Scholar

Lange, S, Rovet, J, Rehm, J, Popova, S. Neurodevelopmental profile of Fetal Alcohol Spectrum Disorder: A systematic review. BMC Psychol. 2017;5(1):22.Google Scholar

Hoyme, HE, Kalberg, WO, Elliott, AJ, Blankenship, J, Buckley, D, Marais, AS, et al. Updated clinical guidelines for diagnosing fetal alcohol spectrum disorders. Pediatrics. 2016;138(2):e20154256.Google Scholar

Brocardo, PS, Gil-Mohapel, J, Wortman, R, Noonan, A, McGinnis, E, Patten, AR, et al. The effects of ethanol exposure during distinct periods of brain development on oxidative stress in the adult rat brain. Alcohol Clin Exp Res. 2017;41(1):26–37.Google Scholar

Bukiya, AN, Dopico, AM. Fetal cerebral circulation as target of maternal alcohol consumption. Alcohol Clin Exp Res. 2018;42(6):1006–18.Google Scholar

Petrelli, B, Bendelac, L, Hicks, GG, Fainsod, A. Insights into retinoic acid deficiency and the induction of craniofacial malformations and microcephaly in fetal alcohol spectrum disorder. Genesis. 2019;57(1):e23278.Google Scholar

Jarmasz, JS, Stirton, H, Basalah, D, Davie, JR, Clarren, SK, Astley, SJ, et al. Global DNA methylation and histone post-translational modifications in human and non-human primate brain in association with prenatal alcohol exposure. Alcohol Clin Exp Res. 2019;43:1145–1162.Google Scholar

Hendrickson, TJ, Mueller, BA, Sowell, ER, Mattson, SN, Coles, CD, Kable, JA, et al. Cortical gyrification is abnormal in children with prenatal alcohol exposure. NeuroImage Clinical. 2017;15:391–400.Google Scholar

Nardelli, A, Lebel, C, Rasmussen, C, Andrew, G, Beaulieu, C. Extensive deep gray matter volume reductions in children and adolescents with fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2011;35(8):1404–17.Google Scholar

Ghazi Sherbaf, F, Aarabi, MH, Hosein Yazdi, M, Haghshomar, M. White matter microstructure in fetal alcohol spectrum disorders: A systematic review of diffusion tensor imaging studies. Human brain mapping. 2019;40(3):1017–36.Google Scholar

Jarmasz, JS, Basalah, DA, Chudley, AE, Del Bigio, MR. Human brain abnormalities associated with prenatal alcohol exposure and fetal alcohol spectrum disorder. Journal of Neuropathology and Experimental Neurology. 2017;76(9):813–33.Google Scholar

Zanghi, CN, Jevtovic-Todorovic, V. A holistic approach to anesthesia-induced neurotoxicity and its implications for future mechanistic studies. Neurotoxicol Teratol. 2017;60:24–32.Google Scholar

Beers, SR, Rofey, DL, McIntyre, KA. Neurodevelopmental assessment after anesthesia in childhood: review of the literature and recommendations. Anesth Analg. 2014;119(3):661–9.Google Scholar

Olutoye, OA, Baker, BW, Belfort, MA, Olutoye, OO. Food and Drug Administration warning on anesthesia and brain development: implications for obstetric and fetal surgery. American Journal of Obstetrics and Gynecology. 2018;218(1):98–102.Google Scholar

Campagne, DM. Antidepressant use in pregnancy: are we closer to consensus? Archives of Women’s Mental Health. 2019;22(2):189–97.Google Scholar

Gao, SY, Wu, QJ, Zhang, TN, Shen, ZQ, Liu, CX, Xu, X, et al. Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies. British Journal of Clinical Pharmacology. 2017;83(10):2134–47.Google Scholar

Shen, ZQ, Gao, SY, Li, SX, Zhang, TN, Liu, CX, Lv, HC, et al. Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies. British Journal of Clinical Pharmacology. 2017;83(4):909–22.Google Scholar

Eke, AC, Saccone, G, Berghella, V. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis. BJOG. 2016;123(12):1900–7.Google Scholar

Reefhuis, J, Devine, O, Friedman, JM, Louik, C, Honein, MA. Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports. BMJ (Clinical Research Ed). 2015;351:h3190.Google Scholar

Berard, A, Zhao, JP, Sheehy, O. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ Open. 2017;7(1):e013372.Google Scholar

Chen, JF, Lee, CF, Chern, Y. Adenosine receptor neurobiology: overview. Int Rev Neurobiol. 2014;119:1–49.Google Scholar

Brent, RL, Christian, MS, Diener, RM. Evaluation of the reproductive and developmental risks of caffeine. Birth Defects Research Part B, Developmental and Reproductive Toxicology. 2011;92(2):152–87.Google Scholar

American College of Obstetricians Gynecologists. Committee Opinion No. 462: Moderate caffeine consumption during pregnancy. Obstetrics and Gynecology. 2010;116(2 Pt 1):467–8.Google Scholar

Peacock, A, Mattick, RP, Bruno, R. A review of caffeine use as a risk or protective factor for women’s health and pregnancy. Curr Opin Psychiatry. 2017;30(4):253–9.Google Scholar

Hvolgaard Mikkelsen, S, Obel, C, Olsen, J, Niclasen, J, Bech, BH. Maternal caffeine consumption during pregnancy and behavioral disorders in 11-year-old offspring: A Danish National Birth Cohort Study. Journal of Pediatrics. 2017;189:120–7e1.Google Scholar

Levine, A, Clemenza, K, Rynn, M, Lieberman, J. Evidence for the risks and consequences of adolescent cannabis exposure. Journal of the American Academy of Child and Adolescent Psychiatry. 2017;56(3):214–25.Google Scholar

Lorenzetti, V, Chye, Y, Silva, P, Solowij, N, Roberts, CA. Does regular cannabis use affect neuroanatomy? An updated systematic review and meta-analysis of structural neuroimaging studies. European Archives of Psychiatry and Clinical Neuroscience. 2019;269(1):59–71.Google Scholar

Scott, JC, Rosen, AFG, Moore, TM, Roalf, DR, Satterthwaite, TD, Calkins, ME, et al. Cannabis use in youth is associated with limited alterations in brain structure. Neuropsychopharmacology. 2019;44(8):1362–69.Google Scholar

Howard, DS, Dhanraj, DN, Devaiah, CG, Lambers, DS. Cannabis use based on urine drug screens in pregnancy and its association with infant birth weight. J Addict Med. 2019;13(6):436–41.Google Scholar

Gunn, JK, Rosales, CB, Center, KE, Nunez, A, Gibson, SJ, Christ, C, et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 2016;6(4):e009986.Google Scholar

Sharapova, SR, Phillips, E, Sirocco, K, Kaminski, JW, Leeb, RT, Rolle, I. Effects of prenatal marijuana exposure on neuropsychological outcomes in children aged 1–11 years: a systematic review. Paediatr Perinat Epidemiol. 2018;32(6):512–32.Google Scholar

Pulli, EP, Kumpulainen, V, Kasurinen, JH, Korja, R, Merisaari, H, Karlsson, L, et al. Prenatal exposures and infant brain: review of magnetic resonance imaging studies and a population description analysis. Human Brain Mapping. 2019;40(6):1987–2000.Google Scholar

American College of Obstetricians and Gynecologists. Committee opinion summary No. 722: marijuana use during pregnancy and lactation. Obstetrics and gynecology. 2017;130(4):931–2.Google Scholar

American College of Obstetricians and Gynecologists. Committee opinion No. 776 summary: immune modulating therapies in pregnancy and lactation. Obstetrics and Gynecology. 2019;133(4):846–9.Google Scholar

Esposito, S, Tenconi, R, Preti, V, Groppali, E, Principi, N. Chemotherapy against cancer during pregnancy: a systematic review on neonatal outcomes. Medicine. 2016;95(38):e4899.Google Scholar

Ngu, SF, Ngan, HY. Chemotherapy in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016;33:86–101.Google Scholar

Cardonick, EH, Gringlas, MB, Hunter, K, Greenspan, J. Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls. American Journal of Obstetrics and Gynecology. 2015;212(5):658 e1–8.Google Scholar

Ikonomidou, C. Chemotherapy and the pediatric brain. Mol Cell Pediatr. 2018;5(1):8.Google Scholar

Scanlon, JW. The neuroteratology of cocaine: background, theory, and clinical implications. Reprod Toxicol 1991;5(2):89–98 .Google Scholar

Chasnoff, IJ, Bussey, ME, Savich, R, Stack, CM. Perinatal cerebral infarction and maternal cocaine use. J. Pediatrics. 1986;108(3):456–9.Google Scholar

Dos Santos, JF, de Melo Bastos Cavalcante, C, Barbosa, FT, Gitai, DLG, Duzzioni, M, Tilelli, CQ, et al. Maternal, fetal and neonatal consequences associated with the use of crack cocaine during the gestational period: a systematic review and meta-analysis. Arch Gynecol Obstet. 2018;298(3):487–503.Google Scholar

Cain, MA, Bornick, P, Whiteman, V. The maternal, fetal, and neonatal effects of cocaine exposure in pregnancy. Clin Obstet Gynecol. 2013;56(1):124–32.Google Scholar

Bower, C, Stanley, FJ, Nicol, DJ. Maternal folate status and the risk for neural tube defects. The role of dietary folate. Ann N Y Acad Sci. 1993;678:146–55.Google Scholar

American College of Obstetricians and Gynecologists. Committee opinion No. 762 summary: prepregnancy counseling. Obstetrics and Gynecology. 2019;133(1):228–30.Google Scholar

De-Regil, LM, Pena-Rosas, JP, Fernandez-Gaxiola, AC, Rayco-Solon, P. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database of Systematic Reviews. 2015(12):CD007950.Google Scholar

Wald, NJ, Morris, JK, Blakemore, C. Public health failure in the prevention of neural tube defects: time to abandon the tolerable upper intake level of folate. Public Health Rev. 2018;39:2.Google Scholar

Au, KS, Findley, TO, Northrup, H. Finding the genetic mechanisms of folate deficiency and neural tube defects-Leaving no stone unturned. American Journal of Medical Genetics Part A. 2017;173(11):3042–57.Google Scholar

Hetzel, BS, Hay, ID. Thyroid function, iodine nutrition and fetal brain development. Clin Endocrinol (Oxf). 1979;11(4):445–60.Google Scholar

Feyrer, J, Politi, D, Weil, DN. The cognitive effects of micronutrient deficiency: evidence from salt iodization in the united states. J Eur Econ Assoc. 2017;15(2):355–87.Google Scholar

Mitra, P, Sharma, S, Purohit, P, Sharma, P. Clinical and molecular aspects of lead toxicity: an update. Crit Rev Clin Lab Sci. 2017;54(7–8):506–28.Google Scholar

Timpo, AE, Amin, JS, Casalino, MB, Yuceoglu, AM. Congenital lead intoxication. Journal of Pediatrics. 1979;94(5):765–7.Google Scholar

Logdberg, B, Brun, A, Berlin, M, Schutz, A. Congenital lead encephalopathy in monkeys. Acta Neuropathologica. 1988;77(2):120–7.Google Scholar

Eto, K, Marumoto, M, Takeya, M. The pathology of methylmercury poisoning (Minamata disease). Neuropathology. 2010;30:471–9.Google Scholar

Takaoka, S, Fujino, T, Hotta, N, Ueda, K, Hanada, M, Tajiri, M, et al. Signs and symptoms of methylmercury contamination in a First Nations community in Northwestern Ontario, Canada. Sci Total Environ. 2014;468–9:950–7.Google Scholar

Grandjean, P, Herz, KT. Methylmercury and brain development: imprecision and underestimation of developmental neurotoxicity in humans. Mt Sinai J Med. 2011;78(1):107–18.Google Scholar

Harada, M. Congenital Minamata disease: intrauterine methylmercury poisoning. Teratology. 1978;18(2):285–8.Google Scholar

Matsumoto, H, Koya, G, Takeuchi, T. Fetal Minamata disease. A neuropathological study of two cases of intrauterine intoxication by a methyl mercury compound. J Neuropathol Exp Neurol 1965;24(4):563–74.CrossRefGoogle ScholarPubMed

Sanfeliu, C, Sebastia, J, Cristofol, R, Rodriguez-Farre, E. Neurotoxicity of organomercurial compounds. Neurotox Res. 2003;5(4):283–305.Google Scholar

Borsari, L, Malagoli, C, Werler, MM, Rothman, KJ, Malavolti, M, Rodolfi, R, et al. Joint effect of maternal tobacco smoking and pregestational diabetes on preterm births and congenital anomalies: a population-based study in northern Italy. J, Diabetes Res. 2018;2018:2782741.Google Scholar

Dhalwani, NN, Szatkowski, L, Coleman, T, Fiaschi, L, Tata, LJ. Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring. Pediatrics. 2015;135(5):859–67.Google Scholar

Holbrook, BD. The effects of nicotine on human fetal development. Birth Defects Res C Embryo Today: Reviews. 2016;108(2):181–92.Google Scholar

Verhagen, EA, Ter Horst, HJ, Kooi, EM, Keating, P, van den Berg, PP, Bos, AF. Prenatal tobacco exposure influences cerebral oxygenation in preterm infants. Early Hum Dev. 2011;87(6):401–6.Google Scholar

El Marroun, H, Schmidt, MN, Franken, IH, Jaddoe, VW, Hofman, A, van der Lugt, A, et al. Prenatal tobacco exposure and brain morphology: a prospective study in young children. Neuropsychopharmacology. 2014;39(4):792–800.Google Scholar

Paus, T, Nawazkhan, I, Leonard, G, Perron, M, Pike, GB, Pitiot, A, et al. Corpus callosum in adolescent offspring exposed prenatally to maternal cigarette smoking. NeuroImage. 2008;40(2):435–41.Google Scholar

Rose-Jacobs, R, Richardson, MA, Buchanan-Howland, K, Chen, CA, Cabral, H, Heeren, TC, et al. Intrauterine exposure to tobacco and executive functioning in high school. Drug Alcohol Depend. 2017;176:169–75.Google Scholar

Kohlmeier, KA. Nicotine during pregnancy: changes induced in neurotransmission, which could heighten proclivity to addict and induce maladaptive control of attention. J Dev Orig Health Dis. 2015;6(3):169–81.Google Scholar

Longo, CA, Fried, PA, Cameron, I, Smith, AM. The long-term effects of prenatal nicotine exposure on verbal working memory: an fMRI study of young adults. Drug Alcohol Depend. 2014;144:61–9.Google Scholar

Tiesler, CM, Heinrich, J. Prenatal nicotine exposure and child behavioural problems. Eur Child Adolesc Psychiatr 2014;23(10):913–29.Google Scholar

Dwyer, JB, McQuown, SC, Leslie, FM. The dynamic effects of nicotine on the developing brain. Pharmacol Ther. 2009;122(2):125–39.Google Scholar

American College of Obstetricians and Gynecologists. Committee opinion No. 721 summary: smoking cessation during pregnancy. Obstet Gynecol. 2017;130(4):929–30.Google Scholar

Wagijo, MA, Sheikh, A, Duijts, L, Been, JV. Reducing tobacco smoking and smoke exposure to prevent preterm birth and its complications. Paediatr Respir Rev. 2017;22:3–10.Google Scholar

American College of Obstetricians and Gynecologists. Committee opinion No. 711 summary: opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017;130(2):488–9.Google Scholar

Kallen, B, Reis, M. Use of tramadol in early pregnancy and congenital malformation risk. Reprod Toxicol 2015;58:246–51.Google Scholar

Brennan, MC, Rayburn, WF. Counseling about risks of congenital anomalies from prescription opioids. Birth Defects Res A Clin Mol Teratol. 2012;94(8):620–5.Google Scholar

Broussard, CS, Rasmussen, SA, Reefhuis, J, Friedman, JM, Jann, MW, Riehle-Colarusso, T, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011;204(4):314.e1–11.Google Scholar

Ornoy, A, Michailevskaya, V, Lukashov, I, Bar-Hamburger, R, Harel, S. The developmental outcome of children born to heroin-dependent mothers, raised at home or adopted. Child Abuse Negl. 1996;20(5):385–96.Google Scholar

Sreetharan, S, Thome, C, Tharmalingam, S, Jones, DE, Kulesza, AV, Khaper, N, et al. Ionizing radiation exposure during pregnancy: effects on postnatal development and life. Radiat Res. 2017;187(6):647–58.Google Scholar

Verreet, T, Verslegers, M, Quintens, R, Baatout, S, Benotmane, MA. Current evidence for developmental, structural, and functional brain defects following prenatal radiation exposure. Neural Plasticity. 2016;2016:1243527.Google Scholar

Frush, DP, Perez, MDR. Children, medical radiation and the environment: an important dialogue. Environmental Res. 2017;156:358–63.Google Scholar

Berrington de Gonzalez, A, Salotti, JA, McHugh, K, Little, MP, Harbron, RW, Lee, C, et al. Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions. Br J Cancer. 2016;114(4):388–94.Google Scholar

Scantlebury, N, Bouffet, E, Laughlin, S, Strother, D, McConnell, D, Hukin, J, et al. White matter and information processing speed following treatment with cranial-spinal radiation for pediatric brain tumor. Neuropsychology. 2016;30(4):425–38.Google Scholar

Zhou, K, Bostrom, M, Ek, CJ, Li, T, Xie, C, Xu, Y, et al. Radiation induces progenitor cell death, microglia activation, and blood-brain barrier damage in the juvenile rat cerebellum. Sci Rep. 2017;7:46181.Google Scholar

Sorrells, SF, Paredes, MF, Cebrian-Silla, A, Sandoval, K, Qi, D, Kelley, KW, et al. Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature. 2018;555(7696):377–81.Google Scholar

Rhinn, M, Dolle, P. Retinoic acid signalling during development. Development. 2012;139(5):843–58.Google Scholar

Adams, J. The neurobehavioral teratology of retinoids: a 50-year history. Birth Defects Res A Clin Mol Teratol. 2010;88(10):895–905.Google Scholar

Lammer, EJ, Chen, DT, Hoar, RM, Agnish, ND, Benke, PJ, Braun, JT, et al. Retinoic acid embryopathy. N Engl J Med. 1985;313(14):837–41.CrossRefGoogle ScholarPubMed

Clotman, F, van Maele-Fabry, G, Chu-Wu, L, Picard, JJ. Structural and gene expression abnormalities induced by retinoic acid in the forebrain. Reprod Toxicol. 1998;12(2):169–76.Google Scholar

Tran, PX, Au, KS, Morrison, AC, Fletcher, JM, Ostermaier, KK, Tyerman, GH, et al. Association of retinoic acid receptor genes with meningomyelocele. Birth Defects Res A Clin Mol Teratol. 2011;91(1):39–43.Google Scholar

Hannigan, JH, Bowen, SE. Reproductive toxicology and teratology of abused toluene. Syst Biol Reprod Med. 2010;56(2):184–200.Google Scholar

Tanoshima, M, Kobayashi, T, Tanoshima, R, Beyene, J, Koren, G, Ito, S. Risks of congenital malformations in offspring exposed to valproic acid in utero: a systematic review and cumulative meta-analysis. Clin Pharmacol Ther. 2015;98(4):417–41.Google Scholar

Jentink, J, Loane, MA, Dolk, H, Barisic, I, Garne, E, Morris, JK, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med. 2010;362(23):2185–93.Google Scholar

Christensen, J, Gronborg, TK, Sorensen, MJ, Schendel, D, Parner, ET, Pedersen, LH, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013;309(16):1696–703.Google Scholar

Ponzano, A, Tiboni, GM. Teratology of valproic acid: an updated review of the possible mediating mechanisms. Minerva Ginecol. 2018;70(3):303–22.Google Scholar

Ornoy, A. Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod Toxicol. 2006;22(2):214–26.Google Scholar